Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy

The response to neoadjuvant chemotherapy in breast cancer patients is usually assessed by pCR and RCB score. However, the prognostic value of these parameters is still in discussion. We showed recently that an epirubicin/docetaxel therapy is associated with an increase in the cell death marker high‐...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Med
Main Authors: Exner, Ruth, Sachet, Monika, Arnold, Tobias, Zinn‐Zinnenburg, Mercedes, Michlmayr, Anna, Dubsky, Peter, Bartsch, Rupert, Steger, Guenther, Gnant, Michael, Bergmann, Michael, Bachleitner‐Hofmann, Thomas, Oehler, Rudolf
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2016
Subjects:
Clinical Cancer Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5055166/
https://ncbi.nlm.nih.gov/pubmed/27457217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.827
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items